Immix Biopharma, Inc. Share Price
NASDAQ: IMMX | Small CapImmix Biopharma, Inc. Stock Performance
Immix Biopharma, Inc. Share Price Today
As of 8 October 2026, Immix Biopharma, Inc.'s share price is $9.48. The stock opened at $9.51, compared to its previous close of $9.63. During today's trading session, Immix Biopharma, Inc.'s share price traded between $9.42 and $9.69, with an average price of $9.55. Over the past 52 weeks, the stock has recorded a high of $15.09 and a low of $2.33. In terms of performance, Immix Biopharma, Inc.'s share price has risen by 6.04% over the last six months and is up 150.13% on a year-on-year basis.
Immix Biopharma, Inc. Share Price Chart
Immix Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
Immix Biopharma, Inc. Annual Profit & Loss
All figures in USD
About Immix Biopharma, Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Immix Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $10.09 | $9.48 | -8.93% |
Sep 2026 | $14.03 | $10.41 | -27.12% |
Aug 2026 | $8.31 | $14.29 | +71.65% |
Jul 2026 | $10.19 | $8.32 | -19.10% |
Jun 2026 | $8.93 | $10.29 | +14.52% |
May 2026 | $8.91 | $8.98 | +0.50% |
Apr 2026 | $9.43 | $8.94 | -2.08% |
Mar 2026 | $8.11 | $9.13 | +13.42% |
Feb 2026 | $5.78 | $8.05 | +38.44% |
Jan 2026 | $5.24 | $5.82 | +11.61% |
Dec 2025 | $4.22 | $5.21 | +22.01% |
Nov 2025 | $3.77 | $4.27 | +12.66% |